Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235
Cancer Research (2008) - Comment
pubmed: 19010894  doi: 10.1158/0008-5472.can-08-1740  issn: 0008-5472  issn: 1538-7445 

Pieter J.A. Eichhorn, Magüi Gili, Maurizio Scaltriti, Violeta Serra, Marta Guzman, Wouter Nijkamp, Roderick L. Beijersbergen, Vanesa Valero, Joan Seoane, René Bernards, José Baselga